最新消息 生華科跨癌種新藥臨床數據正向2024 ESMO年會雙軌發表 Sep 09 2024 最新消息 生華科新藥治罕見兒童癌症 已獲美FDA核准執行 Aug 07 2024 最新消息 生華科新藥臨床成果獲選ESMO發表 臨床數據PI 振奮值得期待 Jul 12 2024 媒體報導 生華科新藥治罕見兒童癌症！已獲美國 FDA 核准執行 Aug 07 2024 媒體報導 生華科狙殺多達8種癌症兩新藥 首進美國癌症研究協會年會找商機 Apr 03 2024 媒體報導 疫情升溫 生華科料將加速收案 Dec 26 2023 期刊 Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study Sep 24 2022 期刊 Protein kinase CK2: a potential therapeutic target for diverse human diseases Jul 20 2021 期刊 Silmitasertib (CX-4945) in combination with gemcitabine and cisplatin as first-line treatment for patients with locally advanced or metastatic cholangiocarcinoma: A phase Ib/II study. Jan 12 2021